The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida

Annals of Internal Medicine

Volumn 136, Issue 11, 2002, Pages 834-844

  Safdar, Nasia ^a   Maki, Dennis G ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; CANDIDA; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; URINE CATHETER; VASCULAR ACCESS;

EID: 0037018951     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-136-11-200206040-00013     Document Type: Review

References (177)

1. Risk factors for nosocomial infection in intensive care. 'Devices vs nature' and goals for the next decade
2. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management
3. Antimictobial-drug resistance
4. Clinical aspects of antimicrobial resistance
5. Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance
6. Vancomycin-resistant enterococci
7. Clostridium difficile-associated diarrhea and colitis
8. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli
9. Nosocomial Candida. Epidemiology, transmission, and prevention
10. Control of colonization and transmission of pathogenic bacteria in the hospital
11. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains
12. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA
13. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin resistant enterococci (VRE) in VRE-colonized patients with acute leukemia
14. Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit
15. Candida colonization and subsequent infections in critically ill surgical patients
16. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies
17. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: Role of antimicrobial therapy in infection control
18. Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: Epidemiology and eradication of the resistant strain from the hospital
19. Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility
20. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility
21. The significance of methicillin-resistant Staphylococcus aureus infection in general surgery: A multivariate analysis of risk factors and preventive approaches
22. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
23. Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated factors and eradication
24. Risk factors for methicillin-resistant: Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital
25. Methicillin-resistant Staphylococcus aureus: Acquisition and risk of death in patients in the intensive care unit
26. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: A retrospective case-control study
27. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
28. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - A preliminary report
29. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemiciy in a university medical center
30. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
31. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality
32. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients
33. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care trait unit
34. Vancomycin-resistant gram-positive cocci: Risk factors for faecal carriage
35. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients
36. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: An important infection control variable
37. Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: Association with antibiotic usage
38. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
39. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection
40. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: A 2-year survey
41. A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci
42. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
43. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution
44. Vancomycin-resistant enterococci in intensive care units: High frequency of stool carriage during a non-outbreak period
45. Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile
46. A nationwide, multicenter, case-control study comparing risk factors treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
47. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak
48. Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species
49. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase
50. Multiply drug resistant Klebsiella pneumoniae (MDRKP) strains: Predictors of acquisition and mortality
51. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition
52. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation
53. Epidemiology of nosocomial infection caused by multi-resistant ESBL-producing Klebsiella
54. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum betalactamase (ESBL-KP) in the intensive care unit
55. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value?
56. Multiple antibiotic-resistant Klebsielia and Escherichia coli in nursing homes
57. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia
58. Antibiotic-associated colitis caused by Clostridium difficile: Relapse and risk factors
59. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients
60. Risk factors for Clostridium difficile toxin-associated diarrhea
61. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak
62. Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients
63. Infection due to Clostridium difficile among elderly residents of a long-term-care facility
64. Clostridium difficile colonization in residents of long-term care facilities: Prevalence and risk factors
65. Epidemic Clostridium difficile-associated diarrhea: Role of second- and third-generation cephalosporins
66. Clostridium difficile colonization and diarrhea at a tertiary care hospital
67. A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea
68. Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients
69. Clostridium difficile colitis: An efficient clinical approach to diagnosis
70. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea
71. Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial
72. Clostridium difficile-associated diarrhea: Epidemiology, risk factors, and infection control
73. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding
74. The impact of Clostridium difficile on a surgical service: A prospective study of 374 patients
75. Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients
76. Risk factors for early recurrent Clostridium difficile-associated diarrhea
77. Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics
78. Risk factors for candidemia in cancer patients: A case-control study
79. Risk factors for nosocomial candidemia: A case-control study in adults without leukemia
80. Risk factors for hospital-acquired candidemia. A matched case-control study
81. Risk factors for candidemia in patients with acute lymphocytic leukemia
82. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation
83. Natural history of bloodstream infections in a burn patient population: The importance of candidemia
84. Risk factors for invasive fungal infections complicating orthotopic liver transplantation
85. Fungal liver infection in marrow transplant recipients: Prevalence at autopsy, predisposing factors, and clinical features
86. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation
87. Candidemia in HIV-infected subjects
88. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999
89. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2
90. Four outbreaks of nosocomial systemic candidiasis
91. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay
92. Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers
93. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
94. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme
95. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial
96. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis
97. A comparison of two antimicrobial-impregnated central venous catheters
98. A novel silver hydrogel-impregnated indwelling urinary catheter reduces CAUTIs: A prospective double blind trial
99. A prospective randomized investigator-blinded trial of a novel nitrofurazone-impregnated urinary catheter
100. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: A multicenter study
101. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: A prospective, randomized, multicenter clinical trial
102. Control of methicillin-resistant Staphylococcus aureus in a burn unit: Role of nurse staffing
103. Eradication of epidemic methicillin-gentamicin resistant staphylococcus aureus in an intensive care nursery
104. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit
105. Effect of an expanded physical facility on nosocomial infections in a neonatal intensive care unit
106. Control of vancomycin-resistant enterococcus in health care facilities in a region
107. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions
108. A MRSA outbreak in an SICU during universal precautions: New epidemiology for nosocomial MRSA: Downside for universal precautions
109. The effectiveness of using preemptive barrier precautions routinely (protective isolation) in all high-risk patients to prevent nosocomial infection with resistant organisms, especially MRSA, VRE and C difficile
110. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia
111. The contribution of a bacterially isolated environment to the prevention of infection in seriously burned patients
112. The use of a laminar airflow isolation system for the treatment of major burns
113. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants
114. Reduction of nosocomial infection during pediatric intensive care by protective isolation
115. Guidelines and audits for use of antimicrobial agents in hospitals
116. Hospital usage of parenteral antimicrobial agents: A gradated utilization review and cost containment program
117. Surveillance of antimicrobial prophylaxis for surgical procedures
118. Infections associated with subclavian dialysis catheters: The key role of nurse training
119. Education of physicians-in-training can decrease the risk for vascular catheter infection
120. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care
121. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study
122. Prevention of peripheral venous catheter complications with an intravenous therapy team: A randomized controlled trial
123. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
124. Yes, Virginia, aseptic technique is very important: Maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia
125. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters
126. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients
127. A randomized trial of a novel 1% chlorhexidine-75% alcohol tincture vs. 10% povidone-iodine for cutaneous disinfection with vascular catheters
128. Novel methods for the prevention of infection of intravascular devices
129. Procedural skills of practicing nephrologists. A national survey of 700 members of the American College of Physicians
130. Catheter-associated urinary tract infections
131. Prevention of nosocomial pneumonia in intubated patients: Respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis
132. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
133. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care
134. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group
135. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection
136. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods
137. The effect of an educational intervention on the use of peri-operative antimicrobial agents
138. Antibiotic resistance. Control strategies
139. Effect of formulary restriction of cefotaxime usage
140. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clildamycin use
141. Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium
142. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus
143. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci
144. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
145. Decreased antimicrobial resistance after changes in antibiotic use
146. New intervention strategies for reducing antibiotic resistance
147. Restriction policies for therapy with combination antibiotics
148. Management of a restricted drugs policy in hospital: The first five years' experience
149. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia
150. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes
151. A computer-assisted management program for antibiotics and other antiinfective agents
152. Removal of nosocomial pathogens from the contaminated glove. Implications for glove reuse and handwashing
153. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit
154. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci
155. The stethoscope: A medical device with potential for amplifying cross-infection of resistant nosocomial organisms in the hospital
156. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
157. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers
158. Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables
159. Guideline for prevention of surgical site infection, 1999
160. Infections due to infusion therapy
161. Risk factors for nosocomial urinary tract infection
162. Guidelines for prevention of nosocomial pneumonia
163. Ventriculostomy-related infections. A prospective epidemiologic study
164. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths
165. Prevention of intravascular catheter-related infections
166. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use
167. Central 169. Venous access for haemodialysis using the Hickman catheter
168. Antibiotic resistance in the intensive care unit
169. Nosocomial outbreaks: The Centers for Disease Control's Hospital Infections Program experience, 1980-1990. Epidemiology Branch, Hospital Infections Program
170. Inactivation of antibiotics and the dissemination of resistance genes
171. Epidemiology, appropriateness, and cost of vancomycin use
172. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
173. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: A meta-analysis
174. Effect of antibiotic therapy on the density of vancomycin resistant enterococci in the stool of colonized patients